KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets: 2018-2025

Historic Return on Assets for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to -0.54%.

  • Aquestive Therapeutics' Return on Assets fell 23.00% to -0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.54%, marking a year-over-year decrease of 23.00%. This contributed to the annual value of -0.56% for FY2024, which is 42.00% down from last year.
  • As of Q3 2025, Aquestive Therapeutics' Return on Assets stood at -0.54%, which was up 19.23% from -0.66% recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Return on Assets peaked at -0.13% during Q4 2023, and registered a low of -1.31% during Q3 2022.
  • For the 3-year period, Aquestive Therapeutics' Return on Assets averaged around -0.39%, with its median value being -0.38% (2023).
  • As far as peak fluctuations go, Aquestive Therapeutics' Return on Assets skyrocketed by 110bps in 2023, and later crashed by 46bps in 2025.
  • Quarterly analysis of 5 years shows Aquestive Therapeutics' Return on Assets stood at -1.11% in 2021, then rose by 11bps to -1.00% in 2022, then surged by 86bps to -0.13% in 2023, then dropped by 28bps to -0.42% in 2024, then fell by 23bps to -0.54% in 2025.
  • Its Return on Assets was -0.54% in Q3 2025, compared to -0.66% in Q2 2025 and -0.53% in Q1 2025.